SecBot SecBot
144 ·Filed Nov 4, 2026

ARQT

Arcutis Biotherapeutics, Inc.
NEUTRAL
Impact 3/10
Horizondays Processed12d 7h ago SEC0001628280-26-070283
Form 144: notice of proposed sale of securities
Actionable Insight • Neutral

Monitor whether the sale actually executes; a single officer sale of this size is routine and not indicative of broader insider sentiment. Watch for any subsequent Form 4 filings to confirm completion.

DirectionNeutral
Confidencemedium
Horizondays

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$27.00
T+0 close · Nov 4, 2026 · via day close
Latest settled
+1.96%
T+5 · $27.53 · next T+20 in 17d
Vs SPY
−1.33%
α at T+5
Latest observation
+2.21%
T+6 · FF3 residual α
  1. T+0 · Nov 5 $27.00entry
  2. T+1 · 11d ago −5.37%α −5.68% · $25.55
  3. T+5 · 5d ago +1.96%α −1.33% · $27.53
  4. T+7 · todayOpen
  5. T+20 · in 17d Pending
  6. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Masaru Matsuda, an officer of Arcutis Biotherapeutics, filed a Form 144 notice of intent to sell 40,000 shares of common stock, with an approximate market value of $1.37 million based on the filing date. The shares were acquired via stock option exercise on January 12, 2024, and the sale is planned for execution on or around November 4, 2026. This represents a relatively small portion of the company's $3.9B market cap and follows recent insider sales totaling $127K in the prior 30 days.

Key Facts

  • Officer Masaru Matsuda filed Form 144 to sell 40,000 shares of common stock.
  • Estimated sale value: approximately $1,372,670.48 based on filing date price.
  • Shares acquired via stock option exercise on January 12, 2024.
  • Proposed sale date: November 4, 2026.
  • Recent insider activity: 1 sell totaling $127K in the 30 days prior to snapshot.
  • Market cap: $3.9B; sale represents ~0.035% of shares outstanding.

Financial Impact

Proposed sale of 40,000 shares worth approximately $1.37 million, or about 0.035% of market cap.

dilution

Risk Factors

  • Form 144 is an intent to sell; the sale may not occur.
  • Insider selling could signal lack of confidence if followed by additional filings.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (14 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001628280-26-070283
Document: 0001628280-26-070283-index.html0001628280-26-070283
Document: 0001628280-26-070283.txt0001628280-26-070283

Track record

34 reports on ARQT

Performance horizon

3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +21.34% at T+60 after the Aug 5, 2026 report. 4 of 4 went positive at some point.

Filters
  1. Nov 13, 20263d ago Press Release Neutral 4/10 Entry $28.26 Now $27.15 −3.93% settles Feb 11
  2. Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $27.39 Now $27.15 −0.86% settles Feb 8
  3. Nov 6, 202610d ago Institutional Cluster Neutral 3/10 Entry $25.55 Now $27.15 +6.26% settles Feb 4
  4. Nov 4, 202612d ago 3/A / CLUSTER / 3 Neutral 2/10 Entry $27.00 Now $27.15 +0.56% settles Feb 3
  5. Nov 4, 202612d ago 144 Neutral 3/10 Viewing Entry $27.00 Now $27.15 +0.56% settles Feb 3
  6. Nov 4, 202612d ago 424B5 Bearish 4/10 Entry $27.00 Now $27.15 −0.56% settles Feb 3
  7. Nov 4, 202612d ago 8-K Neutral 5/10 No price data
  8. Nov 4, 202612d ago Press Release Mixed 6/10 Entry $27.00 Now $27.15 +0.56% settles Feb 3
  9. Nov 2, 202614d ago 144 Neutral 2/10 Entry $32.00 Now $27.15 −15.16% settles Feb 1
  10. Nov 2, 202614d ago 144 Neutral 2/10 Entry $32.00 Now $27.15 −15.16% settles Feb 1
Showing 10 of 34

US Market Status

Market Closed · Opens in 8h 31m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 4, 2026